Video Experimental Relacionado
Updated: Jul 13, 2026
13:13
Single-cell Quantitation of mRNA and Surface Protein Expression in Simian Immunodeficiency Virus-infected CD4+ T Cells Isolated from Rhesus macaques
Published on: September 25, 2018
Control del repunte del SIV a través de interrupciones estructuradas del tratamiento durante la infección temprana
1Research Institute for Genetic and Human Therapy (RIGHT), Medical-Dental Building SW307, 3900 Reservoir Road, NW, Washington, DC 20007, USA.
Science (New York, N.Y.)
|November 25, 2000
Resumen
La interrupción estructurada del tratamiento (STI-HAART) con terapia antirretroviral altamente activa (HAART) suprimió efectivamente el virus de la inmunodeficiencia simiana (SIV) en macacos. Este enfoque mejoró las respuestas inmunológicas y el control viral durante las interrupciones del tratamiento, a diferencia del HAART continuo.
Área de la Ciencia:
- Virología Virología.
- Inmunología Inmunología.
- Farmacología Farmacología.
Sus antecedentes:
- Las infecciones retrovirales agudas plantean desafíos significativos para la salud.
- La terapia antirretroviral altamente activa (HAART) es un tratamiento estándar para la supresión viral.
- Comprender las estrategias de tratamiento que mejoran el control inmune es crucial.
Objetivo del estudio:
- Evaluar la eficacia de la interrupción estructurada del tratamiento de horario fijo (STI-HAART) en comparación con el HAART continuo.
- Evaluar el impacto de STI-HAART en la carga viral y las respuestas inmunes específicas del virus.
- Para determinar el potencial de control viral sostenido después de la interrupción del tratamiento.
Principales métodos:
- Se realizó un ensayo controlado aleatorizado utilizando macacos infectados por el virus de la inmunodeficiencia simiana aguda (SIV).
- Los animales recibieron HAART continua o STI-HAART (3 semanas en marcha, 3 semanas de descanso).
- La carga viral y la respuesta inmune específica del virus de las células T (VIR, por sus siglas en inglés) fueron monitoreadas durante todo el estudio.
Principales resultados:
- Tanto el HAART como el STI-HAART suprimieron efectivamente la carga viral en macacos.
- STI-HAART condujo a un aumento del VIR y el control del rebote viral durante las interrupciones del tratamiento.
- El HAART continuo no aumentó el VIR, y el SIV se recuperó al suspender el tratamiento.
Conclusiones:
- El STI-HAART de horario fijo es una alternativa viable al HAART continuo para el tratamiento temprano de la infección retroviral.
- STI-HAART puede mejorar las respuestas inmunes, contribuyendo a un mejor control viral.
- Esta estrategia es prometedora para el manejo eficaz de las infecciones retrovirales.
Videos de Conceptos Relacionados
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Size and Structure of Viral Genomes
Viral genomes exhibit remarkable diversity in size, structure, and composition, influencing their replication strategies and interactions with host cells. These genomes consist of either DNA or RNA and may be linear or circular. Additionally, they can be single-stranded or double-stranded, with each configuration affecting how the virus propagates within a host. RNA viruses, for instance, generally have smaller genomes than DNA viruses, a factor that contributes to their high mutation rates and...
01:29Respiratory Syncytial Virus Disease
Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:19Inhibitors of Virion Maturation and Assembly
As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...